Frederika A. Van Nimwegen

Amsterdam, NH 1066CX, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA's conclusions from the evaluation of 38 suspected cases.

Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA's conclusions from the evaluation of 38 suspected cases.

Journal: Gene therapy
Published: December 20, 2024

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.

Journal: British journal of cancer
Published: September 18, 2017

Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.

Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.

Journal: Blood
Published: September 18, 2016

Reply to D. Vordermark and T. Pelz and R. Mazzola et al.

Reply to D. Vordermark and T. Pelz and R. Mazzola et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 04, 2016

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 18, 2015

Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.

Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.

Journal: JAMA internal medicine
Published: April 28, 2015

Risk of valvular heart disease after treatment for Hodgkin lymphoma.

Risk of valvular heart disease after treatment for Hodgkin lymphoma.

Journal: Journal of the National Cancer Institute
Published: February 26, 2015

Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays.

Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays.

Journal: International journal of radiation oncology, biology, physics
Published: December 15, 2014

Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma.

Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026